logo

For the Inventor, By the Inventor

San Francisco, CA, United States of America

Matthew Sangyup Lee

This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignees: Exelixis Patent Company LLC, Exelixis, Inc.. Active years: 2012-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew Sangyup Lee. Retrieved from https://idiyas.com/inventor/matthew-sangyup-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 40.0

Average Co-Inventor Count = 17.8

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • San Bruno, CA (US) (2013)
  • San Francisco, CA (US) (2012 - 2014)

Company Filing History:

goldMedal3 out of 13 
 
Exelixis Patent Company LLC
 patents
silverMedal2 out of 177 
 
Exelixis, Inc.
 patents

Years Active: 2012-2014

Loading Chart...
5 patents (USPTO):Explore Patents
1. 8796294 - Inhibitors of the hedgehog pathway (2014-08-05),
2. 8754092 - Inhibitors of the hedgehog pathway (2014-06-17),
3. 8440663 - 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as JAK-2 modulators and methods of use (2013-05-14),
4. 8222263 - Inhibitors of hedgehog pathway (2012-07-17),
5. 8088767 - JAK-2 modulators and methods of use (2012-01-03),

Title: The Innovative Contributions of Matthew Sangyup Lee

Introduction

Matthew Sangyup Lee is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of five patents to his name, Lee's work focuses on innovative compounds that target critical biological pathways.

Latest Patents

Among his latest patents, Lee has developed inhibitors of the hedgehog pathway. These inventions are directed to a compound of Formula I or a single isomer thereof. The compounds can be presented as pharmaceutically acceptable salts, hydrates, solvates, or combinations thereof. Additionally, he has outlined methods for preparing these compounds and their applications in treating cancer.

Career Highlights

Matthew Sangyup Lee has worked with notable companies in the pharmaceutical industry, including Exelixis Patent Company LLC and Exelixis, Inc. His experience in these organizations has allowed him to refine his expertise in drug development and patenting innovative solutions.

Collaborations

Lee has collaborated with several professionals in his field, including Grace Mann and Jeff Z Chen. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Matthew Sangyup Lee's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing cancer treatment. His work continues to impact the industry positively, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…